Results 81 to 90 of about 2,655,093 (273)

Preparation and Evaluation of Glutathione Semisolid Formulation as a Candidate for Anti-wrinkle and Skin-Lightening [PDF]

open access: yesمجله علوم پزشکی صدرا
Introduction: In recent years, there has been a growth in the demand for skincare services and products. In this study, a topical formulation composed of glutathione loaded into niosomes was developed, and its physical, chemical, and microbial ...
Mohammad-Mehdi Khazaei   +4 more
doaj   +1 more source

Topical Administration of a Soluble TNF Inhibitor Reduces Infarct Volume After Focal Cerebral Ischemia in Mice

open access: yesFrontiers in Neuroscience, 2019
Background Tumor necrosis factor, which exists both as a soluble (solTNF) and a transmembrane (tmTNF) protein, plays an important role in post-stroke inflammation.
M. Yli-Karjanmaa   +10 more
semanticscholar   +1 more source

Scabies: Application of the Novel Identify-Isolate-Inform Tool for Detection and Management [PDF]

open access: yes, 2020
Scabies is a highly contagious, globally prevalent, parasitic skin infestation caused by Sarcoptes scabiei var. hominis, also known as the itch mite.
Al-Wabel, Abdussalam   +7 more
core  

NGX-4010, a capsaicin 8% patch, for the treatment of painful HIV-associated distal sensory polyneuropathy: integrated analysis of two phase III, randomized, controlled trials [PDF]

open access: yes, 2013
BACKGROUND HIV-associated distal sensory polyneuropathy (HIV-DSP) is the most frequently reported neurologic complication associated with HIV infection.
Brew, Bruce J   +9 more
core   +1 more source

A Randomized, Double-Blinded, Placebo-Controlled, Cross Over Study Evaluating the Efficacy and Safety of Timolol Ophthalmic Solution as an Acute Treatment of Migraine [PDF]

open access: yes, 2020
Introduction. Daily oral beta-adrenoreceptor antagonist has been shown to be effective in preventing migraine headaches. Timolol 0.5% ophthalmic solution is a non-selective beta-adrenoreceptor antago- nist, where the primary use is for glaucoma.
Aggarwal, Dipika   +10 more
core   +2 more sources

Central Serous Chorioretinopathy in a 14-year-old atopic boy: a case report

open access: yesItalian Journal of Pediatrics, 2023
Background Corticosteroids are widely used in medicine. Few cases of central serous chorioretinopathy (CSC) have been reported following topical corticosteroid administration.
Stefano Ranno   +5 more
doaj   +1 more source

mRNA-Based Nanomedicinal Products to Address Corneal Inflammation by Interleukin-10 Supplementation

open access: yesPharmaceutics, 2021
The anti-inflammatory cytokine Interleukin-10 (IL-10) is considered an efficient treatment for corneal inflammation, in spite of its short half-life and poor eye bioavailability. In the present work, mRNA-based nanomedicinal products based on solid lipid
Itziar Gómez-Aguado   +8 more
doaj   +1 more source

Topical Administration of Bosentan Prevents Retinal Neurodegeneration in Experimental Diabetes

open access: yesInternational Journal of Molecular Sciences, 2018
Experimental evidence suggests that endothelin 1 (ET-1) is involved in the development of retinal microvascular abnormalities induced by diabetes. The effects of ET-1 are mediated by endothelin A- and B-receptors (ETA and ETB).
P. Bogdanov   +13 more
semanticscholar   +1 more source

An Evaluation of the in vivo Safety of Nonporous Silica Nanoparticles: Ocular Topical Administration versus Oral Administration

open access: yesScientific Reports, 2017
Nonporous silica nanoparticles (SiNPs) have potential as promising carriers for ophthalmic drugs. However, the in vivo safety of ocular topical SiNPs remains unclear.
Martha A. Kim   +6 more
semanticscholar   +1 more source

Exploratory study on the efficacy of topical pan-JAK inhibitor in ocular and skin GVHD in a sclerodermatous GVHD mouse model

open access: yesScientific Reports
Systemic administration of Janus kinase (JAK) inhibitors is effective in treating chronic graft-versus-host disease (cGVHD) but is associated with side effects. Topical drug administration effectively minimizes side effects.
Shinri Sato   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy